Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B

Cancer Immunology, Immunotherapy

Volumn 53, Issue 5, 2004, Pages 461-470

  Kim, Hyoung Ran ^a   Park, Hyun Joo ^a   Park, Jeon Han ^a   Kim, Se Jong ^a   Kim, Kunhong ^a   Kim, Jongsun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Cytotoxicity; Death receptors ligands; Hepatocellular carcinoma cells; NK cells; Perforin and granzymes

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; TNFRSF10A PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL STRAIN HEPG2; CELL STRAIN K 562; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LABELING INDEX; LEUKEMIA CELL; LIVER CELL; LIVER CELL CARCINOMA; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TARGET CELL; TARGET CELL DESTRUCTION; TUMOR IMMUNITY; TUMOR NECROSIS; WESTERN BLOTTING; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GENETICS; IMMUNOLOGY; LEUKEMIA; LIVER TUMOR; METABOLISM; NECROSIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASES; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; NECROSIS; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342566957     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0461-0     Document Type: Article

References (63)

1. Arase H, Arase N, Saito T (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235
2. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305
3. Chuang W, Liu HW, Chang WY (1990) Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 65:926
4. Duke RC, Chervenak R, Cohen JJ (1983) Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci USA 80:6361
5. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383
6. Feldmann G (1997) Liver Apoptosis. J Hepatol 26:1
7. Fernandes-Alnemri T, Litwack G, Alnemri ES (1994) CPP32: a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269:30761
8. Galle PR, Hofmann WJ, Walczak H, Schller H, Otto G, Stremmel W, Krammer PH, Runkel L (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223
9. Galle PR, Krammer PH (1998) CD95-induced apoptosis in human liver disease. Semin Liver Dis 18:141
10. Gorelik E, Rosen B, Copeland D, Weatherly B, Herberman RB (1984) Evaluation of the role of natural killer cells in radiation-induced leukemogenesis in mice. J Natl Cancer Inst 72:1397
11. Higaki K, Yano H, Kojiro M (1996) Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 149:429
12. Hirofuji H, Kakumu S, Fiji A, Ohtani Y, Murase K, Tahara H (1987) Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine induced activity of effector cells. Clin Exp Immunol 68:348
13. Holcik M, Gibson H, Korneluk RG (2001) XIAP: apoptotic brake and promissing therapeutic target. Apoptosis 6:253
14. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190
15. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564
16. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H (1994) Cytotoxicity mediated by T-cells and natural killer cells is greatly impaired in perforin deficient mice. Nature 369:31
17. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 163:5358
18. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H (1999) Expression and function of TNF-related apoptosis-inducing ligand on murine activates NK cells. J Immunol 163:1906
19. Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA (2002) TRAIL-mediated apoptosis requires NF-kB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatology 36:1498
20. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S (1997) Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:409
21. Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER (1985) Identification of a membrane associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 82:1204
22. Lamboley C, Bringuier AF, Camus E, Lardeux B, Groyer A, Feldmann G (2002) Overexpression of the mouse Fas gene in human Hep3B hepatoma cells overcomes their resistance to Fas-mediated apoptosis. J Hepatol 36:385
23. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER (1996) Perfolin, Fas ligand, and tumor necrosis factor are the major cytototoxic molecules used by lymphokine-activated killer cells. J Immunol 157:1919
24. Leibson PJ (1997) Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655
25. Lowin B, Beermann F, Schmidt A, Tschopp J (1994) A null mutation in the perforin gene impairs cytolytic T lymphocyte-and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 91:11571
26. Matzinger P (1991) The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185
27. Medema JP, de Jong J, Peltenburg LTC, Verdegaal EME, Gorter A, Bres SA, Franken KLMC, Hahne M, Albar JP, Melief CJM, Offringa R (2001) Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 98:11515
28. Montel AH, Bochan MR, Hobbs JA, Lynch DH, Brahmi Z (1995) Fas involvement in cytotoxicity mediated by human NK cells. Cell Immunol 166:236
29. Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H, Yamada T, Okumura K, Nakano H (1999) The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo? Hepatology 30:413
30. Nakajima T, Mizushima N, Kanai K (1987) Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Jpn J Clin Oncol 17:327
31. Natoli G, Ianni G, Costanzo A, Petrillo GD de, Ilari I, Chrillo P, Balsano C, Levrero M (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11:1157
32. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller D (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37
33. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806
34. Oshmi Y, Oda S, Honda Y, Nagata S, Miyazaki S (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157:2909
35. 2+ response patterns in target cells attacked by human natural killer cells. J Physiol 495:319
36. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687
37. Podack ER, Hengartner H, Lichtenheld MG (1991) A central role of perforin in cytolysis? Annu Rev Immunol 9:129
38. Riccardi C, Barlozzari CT, Santoni A, Herberman RB, Cesarini C (1981) Transfer of cyclophosphamide-treated mice of natural killer cells and in vivo natural reactivity against tumors. J Immunol 126:1284
39. Rodella L, Zamai L, Rezzani R, Artico M, Peri G, Falconi M, Facchini A, Pelusi G, Vitale M (2001) Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells. Br J Haematol 115:442
40. Sato T, Irie S, Kitada S, Reed JC (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411
41. Screpanti V, Wallin RPA, Ljunggren HG, Grandien A (2001) A central role for death-receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol 167:2068
42. Shi L, Kraut RP, Aebersold R, Greenberg AH (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175:553
43. Shin EC, Shin JS, Park JH, Kim JJ, Kim H, Kim S (1998) Expression of Fas-related genes in human hepatocellular carcinomas. Cancer Lett 134:155
44. Shin EC, Shin WC, Choi Y, Kim H, Park JH, Kim S (2001) Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells. Cancer Immunol Immunother 50:23
45. Shin EC, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong SS, Park JH (2002) Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin. Exp Mol Med 34:114
46. Smyth MJ, Trapani JA (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202
47. Son K, Kew M, Rabson AR (1982) Depressed natural killer cell activity in patients with hepatocellular carcinoma. Cancer 50:2820
48. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H, Okumura K (2001) Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7:94
49. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K (1998) Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 83:58
50. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47:187
51. Vujanovic NL, Nagashima S, Herberman RB, Whiteside TL (1996) Nonsecretory apoptotic killing by human NK cells. J Immunol 157:1117
52. Wahlberg BJ, Burholt DR, Kornblith P, Richards TJ, Bruffsky A, Herberman RB, Vujanovic NL (2001) Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay. J Immunol Methods 253:69
53. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157
54. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MT, Young JD, Ahmed R, Clark WR (1994) Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 91:10854
55. Whiteside TL, Herberman RB (1995) The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7:704
56. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673
57. Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267
58. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806
59. Yagita H, Nakata M, Kawasaki A, Shinkai Y, Okumura K (1992) Role of perforin in lymphocyte-mediated cytolysis. Adv Immunol 51:215
60. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T, Suzuki A (2000) Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32:482
61. Young JD (1989) Killing of target cells by lymphocytes: a mechanistic view. Physiol Rev 69:250
62. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B (1998) NK-cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 188:2375
63. Zychlinsky A, Zheng LM, Liu CC, Young JD (1991) Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 146:393